VERU INC. Shareholders' Equity
VERU INC. (VERU) had Shareholders' Equity of $28.38 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $28.38M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $34.79M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $37.12M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $18.33M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $28.38M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $34.79M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $37.12M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $18.33M 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $15.34M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $21.05M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $26.63M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $32.32M 10-Q · filed 2026-08-10 | |
| 2024-06-30 | $37.62M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $45.21M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $51.60M 10-Q · filed 2025-08-12 | |
| 2023-09-30 | $19.68M 10-K · filed 2025-12-17 | $17.78M 10-K · filed 2023-12-08 |
| 2023-06-30 | $20.65M 10-Q · filed 2024-08-08 | $34.39M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $21.81M 10-Q · filed 2024-08-08 | $16.72M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $49.19M 10-Q · filed 2024-08-08 | $49.10M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $82.80M 10-K · filed 2024-12-16 | $80.84M 10-K · filed 2022-12-05 |
| 2022-06-30 | $116.87M 10-Q/A · filed 2023-11-15 | |
| 2022-03-31 | $136.00M 10-Q/A · filed 2023-11-15 | |
| 2021-12-31 | $148.00M 10-Q/A · filed 2023-11-15 | |
| 2021-09-30 | $154.52M 10-K/A · filed 2024-04-01 | $152.29M 10-K · filed 2021-12-02 |
| 2021-06-30 | $154.97M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $155.50M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $48.75M 10-Q · filed 2022-08-11 | |
| 2020-09-30 | $30.11M 10-K · filed 2022-12-05 | |
| 2020-06-30 | $41.28M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $31.11M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $29.64M 10-Q · filed 2021-08-12 | |
| 2019-09-30 | $32.33M 10-K · filed 2021-12-02 | |
| 2019-06-30 | $34.74M 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $33.54M 10-Q · filed 2020-08-13 | |
| 2018-12-31 | $36.88M 10-Q · filed 2020-08-13 | |
| 2018-09-30 | $29.48M 10-K · filed 2020-12-10 | |
| 2018-06-30 | $35.87M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $41.33M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $44.75M 10-Q · filed 2019-08-08 | |
| 2017-09-30 | $48.45M 10-K · filed 2019-12-12 | |
| 2017-06-30 | $32.81M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $33.53M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $35.24M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $33.93M 10-K · filed 2018-12-13 | |
| 2016-06-30 | $35.51M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $34.85M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $34.72M 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $33.13M 10-K · filed 2018-01-02 | |
| 2015-06-30 | $32.38M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $31.06M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $29.26M 10-Q · filed 2015-02-03 | |
| 2014-09-30 | $28.07M 10-K · filed 2018-01-02 | |
| 2014-06-30 | $28.97M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $27.75M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $29.27M 10-Q · filed 2014-02-03 | |
| 2013-09-30 | $31.40M 10-K · filed 2016-12-12 | |
| 2013-06-30 | $26.73M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $25.89M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $24.48M 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $24.22M 10-K · filed 2015-12-02 | |
| 2012-06-30 | $19.99M 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $17.34M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $16.96M 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $16.75M 10-K · filed 2014-12-02 | |
| 2011-06-30 | $13.46M 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $16.13M 10-K · filed 2013-12-03 | |
| 2009-09-30 | $12.95M 10-K · filed 2012-12-04 | |
| 2008-09-30 | $9.71M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |